Perrigo Company PLC当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在药品行业排名46/159位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价18.67。中期看,股价处于下降通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
Perrigo Company PLC评分
相关信息
行业排名
46 / 159
全市场排名
143 / 4563
所属行业
药品
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看好
Perrigo Company PLC亮点
亮点风险
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
公司代码PRGO
公司Perrigo Company PLC
CEOLockwood-Taylor (Patrick)
网址https://www.perrigo.com/
常见问题
Perrigo Company PLC(PRGO)的当前股价是多少?
Perrigo Company PLC(PRGO)的当前股价是 15.065。
Perrigo Company PLC的股票代码是什么?
Perrigo Company PLC的股票代码是PRGO。
Perrigo Company PLC股票的52周最高点是多少?
Perrigo Company PLC股票的52周最高点是30.930。
Perrigo Company PLC股票的52周最低点是多少?
Perrigo Company PLC股票的52周最低点是12.170。
Perrigo Company PLC的市值是多少?
Perrigo Company PLC的市值是2.07B。
Perrigo Company PLC的净利润是多少?
Perrigo Company PLC的净利润为-171.80M。
现在Perrigo Company PLC(PRGO)的股票是买入、持有还是卖出?
根据分析师评级,Perrigo Company PLC(PRGO)的总体评级为持有,目标价格为18.667。